Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 |
filingDate |
2012-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf1f8899f6cbca55dc54c31ce5937564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3eded024e4a8faaf147c93b78ef7d8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_185b98e2dfa7902b9b0db1e8c0b61c94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af2b239690cd15ccf84072a5693657e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e232b788c9e4a6f9f5cd6154890b2871 |
publicationDate |
2014-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20140043755-A |
titleOfInvention |
Lixenatide and Metformin for the Treatment of Type 2 Diabetes |
abstract |
The present invention relates to pharmaceutical combinations for glycemic control in patients with type 2 diabetes. FIELD OF THE INVENTION The present invention relates to a combination of lixenatide (AVE0010), a GLP-1 agonist and metformin. |
priorityDate |
2011-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |